首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >An insight on the anatomical and functional consequences of aflibercept therapy in age-related macular degeneration
【24h】

An insight on the anatomical and functional consequences of aflibercept therapy in age-related macular degeneration

机译:关于年龄相关性黄斑变性的Aflibercept治疗的解剖学和功能后果的探讨

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Evaluation of anatomical and functional recovery of the retina after aflibercept therapy in neovascular age-related macular degeneration. Materials and methods: This prospective study enrolled 33 eyes of 33 naive age-related macular degeneration patients with an average age of 69 (55-82) years. Following a thorough ophthalmological examination, baseline color fundus photography, optical coherence tomography and fluorescein angiography were used to assess the angiographic characteristics and classification of the lesions. Multifocal electroretinography and microperimetry were recorded. In the first three months, all patients received three consecutive intravitreal aflibercept injections on a monthly basis. After the initial three doses, non-responders received additional afibercept injections. The baseline, 3rd and 6th month data were recorded for analysis. Results: The baseline average best-corrected visual acuity (1.05 log MAR) improved dramatically to 0.9 log MAR in the 3rd and 6th months, respectively. The baseline average central macular thickness of 358.5 +/- 232.1 mu m decreased significantly to 273.0 +/- 109.9 mu m and 245.5 +/- 109.3 mu m in the 3rd and 6th months, respectively. The average thickness of the central 1 mm macular region decreased significantly from 349.5 +/- 96.4 mu m to the 3rd and 6th month values of 320.6 +/- 101.9 and 290.5 +/- 86.4 mu m, respectively. While the mean retinal sensitivity increased significantly from 4.7 +/- 3.0 dB to 6.9 +/- 3.4 Db, local deficit decreased from -11.6 +/- 4.6 dB to -9.4 +/- 4.6 dB. Significant improvements were also observed in all rings of N1 and P1 waves. Conclusion: Intravitreal aflibercept therapy resulted in significant morphological improvements that were easily identifiable during the 3rd month. Electrophysiological improvements were delayed only to become statistically significant in the 6th month. However, it has been shown that visual acuity and optical coherence tomography parameters alone may be insufficient for both the morphological and functional assessment of the retina.
机译:背景:在常见的心血管年龄相关性黄斑变性后视网膜治疗后视网膜的解剖学和功能恢复的评价。材料和方法:该前瞻性研究纳入33只幼稚与年龄相关的黄斑患者的33只,平均年龄为69(55-82)岁。在彻底的眼科检查后,基线颜色眼底摄影,光学相干断层扫描和荧光素血管造影用于评估病变的血管造影特征和分类。记录多灶性电型造影和微型仪。在前三个月内,所有患者每月接受三次连续玻璃体玻璃体术术。在初始三个剂量之后,非响应者接受了额外的AFIBRESCEIVER。记录基线,第3个和第6个月数据进行分析。结果:基线平均最佳纠正的视力(1.05 Log Mar)分别在第3和第6个月内显着提高到0.9日志。 358.5 +/-232.1μm的基线平均中央黄斑厚度分别在第3和第6个月内显着降至273.0 +/- 109.9 mu m和245.5 +/-109.3μm。中央1毫米黄斑地区的平均厚度显着从349.5 +/- 96.4 mu m显着降至320.6 +/- 101.9和290.5 +/- 86.4 mu m的3个月。虽然平均视网膜敏感度从4.7 +/- 3.0 dB增加到6.9 +/- 3.4 dB,但局部赤字从-11.6 +/- 4.6 dB减少到-9.4 +/- 4.6 dB。在N1和P1波的所有环中也观察到显着的改进。结论:玻璃体外嗜睡治疗导致显着的形态改善,在第3个月内很容易识别。电生理改善延迟只会在第6个月内变得统计学意义。然而,已经表明,对于视网膜的形态和功能评估,单独的视力和光学相干断层摄影参数可能不足。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号